- The key vendors in the global clinical trial supply and logistics market 2015-2019 are Deutsche Bahn AG, Deutsche Post DHL, FedEx and United Parcel Service of America Inc. (UPS)
London, 08 July 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global clinical trial supply and logistics market 2015-2019. Customers are increasingly opting for biopharmaceutical drugs rather than chemical pharmaceutical drugs for the treatment of some diseases such as diabetes, cancer, and genetic diseases because biopharmaceutical drugs offer several advantages. The global clinical trial supply and logistics market 2015-2019 is expected to grow at a CAGR of 8.87% during the period 2014-2019.
The market is expected to grow at a moderate rate during the forecast period, driven by the high demand for new pharmaceutical products and the increased demand for the outsourcing of R&D activities. This market is expected to witness an increase in demand from emerging markets such as India, China, Brazil, and Eastern Europe.
“The contract research organization companies are becoming more competitive because of the entry of many CROs. These CROs are attempting to expand and differentiate their services by practicing forward and backward integration,” says Faisal Ghaus, Vice President of Technavio Research.
“CROs are practicing forward integration to market drugs and backward integration in the drug discovery process to provide complete pharmaceutical service solutions.”
To define the market conditions in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
